Discover

CAPR
Capricor Therapeutics, Inc.
4.09
2 x 4.03
1 x 4.50
bid
ask
-
0.09
2.15%
240 @ 04:00 PM
4.15 +0.06 (1.45%)
Ytd-85.83%
1y-49.32%
4.05
day range
4.70
3.85
52 week range
35.34
Open4.16Prev Close4.18Low4.05High4.70Mkt Cap235.22M
Vol3.47MAvg Vol2.75MEPS-2.32P/E-1.76Forward P/E-35.03
Beta0.42Short Ratio13.95Inst. Own59.73%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1150-d Avg22.65200-d Avg23.271yr Est53.60

CAPR News

Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR
gurufocus.com
Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100

Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100

Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR
prnewswire.com
Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100

/PRNewswire/ -- - ClaimsFiler, a FREE shareholder information service, reminds investors that they h

Kaplan Fox Reminds Capricor Therapeutics, Inc. (CAPR) Investors of a Securities Class Action Deadline on September 28, 2026
newsfilecorp.com
Kaplan Fox Reminds Capricor Therapeutics, Inc. (CAPR) Investors of a Securities Class Action Deadlin

New York, New York--(Newsfile Corp. - August 7, 2026) - Kaplan Fox & Kilsheimer LLP announces that a

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP Before Application Deadline
globenewswire.com
Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsu

SAN FRANCISCO, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Hagens Berman encourages investors in Capricor Ther

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
newsfilecorp.com
Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsu

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 7, 2026) - Kahn Swick & Foti

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR
globenewswire.com
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel

NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,

INVESTOR NOTICE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit - CAPR
gurufocus.com
INVESTOR NOTICE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to L

INVESTOR NOTICE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to L

INVESTOR NOTICE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit - CAPR
prnewswire.com
INVESTOR NOTICE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to L

SAN DIEGO, Aug. 7, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP  announces that purchasers

Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR
globenewswire.com
Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100

NEW ORLEANS, Aug. 07, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service,

$CAPR Court News: Capricor Therapeutics Securities Fraud Class Action Deadline is Imminent – Contact BFA Law before September 28
globenewswire.com
$CAPR Court News: Capricor Therapeutics Securities Fraud Class Action Deadline is Imminent – Contact

NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP

INVESTOR ALERT: Capricor Therapeutics, Inc. (CAPR) Investors with Substantial Losses Have Opportunity to Lead the Capricor Class Action Lawsuit
newsfilecorp.com
INVESTOR ALERT: Capricor Therapeutics, Inc. (CAPR) Investors with Substantial Losses Have Opportunit

San Diego, California--(Newsfile Corp. - August 6, 2026) - Robbins Geller Rudman & Dowd LLP announce

Kaplan Fox Encourages Investors of Capricor Therapeutics, Inc. (CAPR) Who Suffered Losses to Contact the Firm Before September 28, 2026
newsfilecorp.com
Kaplan Fox Encourages Investors of Capricor Therapeutics, Inc. (CAPR) Who Suffered Losses to Contact

New York, New York--(Newsfile Corp. - August 6, 2026) - Kaplan Fox & Kilsheimer LLP announces that a

ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR
newsfilecorp.com
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Capricor Therapeutics, Inc. Investors to Secure Cou

New York, New York--(Newsfile Corp. - August 6, 2026) - WHY: Rosen Law Firm, a global investor right

CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit
prnewswire.com
CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportuni

SAN FRANCISCO, Aug. 6, 2026 /PRNewswire/ -- Hagens Berman encourages investors in Capricor Therapeut

Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
gurufocus.com
Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Have Opportunity to Lead Securities F

Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Have Opportunity to Lead Securities F

Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
prnewswire.com
Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Have Opportunity to Lead Securities F

BENSALEM, Pa., Aug. 6, 2026 /PRNewswire/ -- The Law Offices of Howard G.

Bronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
feeds.newsfilecorp.com
Bronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action F

New York, New York--(Newsfile Corp. - August 6, 2026) - Bronstein, Gewirtz and Grossman, LLC, a nati

Bronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
prnewswire.com
Bronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action F

NEW YORK, Aug. 6, 2026 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized i

CAPR SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 29, 2026
newsfilecorp.com
CAPR SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action L

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff

Kaplan Fox Reminds Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors with Significant Losses to Seek a Leadership Role Before Deadline on September 28, 2026
globenewswire.com
Kaplan Fox Reminds Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors with Significant Losses to S

NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class actio

CAPR Shareholder Alert: Capricor Therapeutics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky
businesswire.com
CAPR Shareholder Alert: Capricor Therapeutics, Inc. Securities Class Action Lawsuit - Investors With

NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky, LLP notifies investors in Capricor Therapeutics, Inc. (

SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of September 28, 2026 in Capricor Therapeutics, Inc. Lawsuit - CAPR
prnewswire.com
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of September 28, 2026 in Capricor Therap

A securities class action alleges Capricor Therapeutics told investors its Phase 3 HOPE-3 results we

CAPR Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Capricor Therapeutics, Inc. Class Action Lawsuit
globenewswire.com
CAPR Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Capric

SAN DIEGO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a securities class a

Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPR
prnewswire.com
Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discus

LOS ANGELES, Aug. 6, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action laws

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
prnewswire.com
CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SB

LOS ANGELES, Aug. 6, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national sharehold

CAPR Alert: Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, September 28, 2026 Lead Plaintiff Deadline
globenewswire.com
CAPR Alert: Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Urged to Contact Hagens Berman; Sec

SAN FRANCISCO, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Hagens Berman encourages investors in Capricor Ther

CAPR CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 29, 2026
businesswire.com
CAPR CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action

NEW YORK--(BUSINESS WIRE)---- $CAPR #CAPR--Faruqi & Faruqi, LLP, a leading national securities law f

Kaplan Fox Urges Investors of Capricor Therapeutics, Inc. (CAPR) with Significant Losses to Seek a Leadership Role Before September 28, 2026
newsfilecorp.com
Kaplan Fox Urges Investors of Capricor Therapeutics, Inc. (CAPR) with Significant Losses to Seek a L

New York, New York--(Newsfile Corp. - August 5, 2026) - Kaplan Fox & Kilsheimer LLP announces that a

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR
newsfilecorp.com
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel

New York, New York--(Newsfile Corp. - August 5, 2026) - WHY: Rosen Law Firm, a global investor right

Capricor (CAPR) Securities Investigation Notice - Levi & Korsinsky
prnewswire.com
Capricor (CAPR) Securities Investigation Notice - Levi & Korsinsky

CAPR shareholders saw a 60% to 70% drop after FDA briefing documents identified significant concerns

Levi & Korsinsky Reminds Capricor Therapeutics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 28, 2026 - CAPR
prnewswire.com
Levi & Korsinsky Reminds Capricor Therapeutics Investors of the Pending Class Action Lawsuit With a

Wall Street's view of Capricor Therapeutics reversed within hours after FDA briefing documents alleg

CAPR INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
businesswire.com
CAPR INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Capricor Therapeutics, Inc. Inv

SAN DIEGO--(BUSINESS WIRE)---- $CAPR #CAPR--The case alleges Capricor Therapeutics and certain of it

CAPR Legal News: Capricor Therapeutics Hit with Securities Fraud Class Action over Alleged Misrepresentations about its Clinical Data – Contact BFA Law
globenewswire.com
CAPR Legal News: Capricor Therapeutics Hit with Securities Fraud Class Action over Alleged Misrepres

NEW YORK, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
globenewswire.com
Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsu

NEW YORK and NEW ORLEANS, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF p

ROSEN, LEADING INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR
globenewswire.com
ROSEN, LEADING INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel

NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,

CAPRICOR INVESTOR ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Capricor Therapeutics, Inc. and Encourages Investors to Contact the Firm
globenewswire.com
CAPRICOR INVESTOR ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been

Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered L

Kaplan Fox & Kilsheimer LLP Alerts Capricor Therapeutics, Inc. (CAPR) Investors to a Securities Class Action Deadline on September 28, 2026
newsfilecorp.com
Kaplan Fox & Kilsheimer LLP Alerts Capricor Therapeutics, Inc. (CAPR) Investors to a Securities Clas

New York, New York--(Newsfile Corp. - August 4, 2026) - Kaplan Fox & Kilsheimer LLP announces that a

Deadline Approaching: Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Urged to Contact Law Offices of Howard G. Smith
gurufocus.com
Deadline Approaching: Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Urged to Contac

Law Offices of Howard G. Smith reminds investors of the upcoming September 28, 2026 deadline to file

Lowey Dannenberg, P.C. is Investigating Capricor Therapeutics, Inc. (NASDAQ: CAPR) for Potential Violations of the Federal Securities Laws
globenewswire.com
Lowey Dannenberg, P.C. is Investigating Capricor Therapeutics, Inc. (NASDAQ: CAPR) for Potential Vio

NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtainin

Deadline Alert: Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
businesswire.com
Deadline Alert: Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Urged To Contact Glan

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming Se

Deadline Approaching: Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Urged to Contact Law Offices of Howard G. Smith
businesswire.com
Deadline Approaching: Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Urged to Contac

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming Sep

CAPRICOR THERAPEUTICS, INC. (CAPR) INVESTOR ALERT Investors With Large Losses in Capricor Therapeutics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
globenewswire.com
CAPRICOR THERAPEUTICS, INC. (CAPR) INVESTOR ALERT Investors With Large Losses in Capricor Therapeuti

NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has

Bronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
feeds.newsfilecorp.com
Bronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action F

New York, New York--(Newsfile Corp. - August 4, 2026) - Bronstein, Gewirtz and Grossman, LLC, a nati

Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors with Significant Losses to Contact the Firm Before September 28, 2026
globenewswire.com
Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors with Significant Losses t

Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Th

CAPR INVESTOR NOTICE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead the Capricor Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
globenewswire.com
CAPR INVESTOR NOTICE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity

SAN DIEGO, Aug. 04, 2026 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announ

CAPR Stock Drop: Capricor Therapeutics Clinical Data Leads to 64% Stock Drop and Securities Fraud Class Action for Investors
prnewswire.com
CAPR Stock Drop: Capricor Therapeutics Clinical Data Leads to 64% Stock Drop and Securities Fraud Cl

Capricor Therapeutics, Inc. has been sued for securities fraud over alleged misstatements about Dera

INVESTOR ALERT: Securities Class Action Filed Against Capricor Therapeutics, Inc. – Investors Encouraged to Contact Kirby McInerney LLP
businesswire.com
INVESTOR ALERT: Securities Class Action Filed Against Capricor Therapeutics, Inc. – Investors Encour

NEW YORK--(BUSINESS WIRE)---- $CAPR #classaction--The law firm of Kirby McInerney LLP announces that

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit
prnewswire.com
CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit

NEW YORK, Aug. 3, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, annou

CAPR Class Action Lawsuit FILED: Capricor Therapeutics Sued for Securities Fraud after Stock Drops 64% Leading to Securities Fraud Case – Investors Urged to Contact BFA Law
businesswire.com
CAPR Class Action Lawsuit FILED: Capricor Therapeutics Sued for Securities Fraud after Stock Drops 6

NEW YORK--(BUSINESS WIRE)---- $CAPR #BFA--Capricor Therapeutics Sued for Securities Fraud after Stoc

Kaplan Fox & Kilsheimer LLP Alerts Capricor Therapeutics, Inc. (CAPR) Investors to a Securities Class Action Deadline on September 28, 2026
newsfilecorp.com
Kaplan Fox & Kilsheimer LLP Alerts Capricor Therapeutics, Inc. (CAPR) Investors to a Securities Clas

New York, New York--(Newsfile Corp. - August 3, 2026) - Kaplan Fox & Kilsheimer LLP announces that a